SEC Form 4 · accession 0001140361-17-011621
Westlake Chemical Partners LP · WLKP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Lumpkins
Director
Period of report
Mar 9, 2017
Accepted (ET)
Mar 10, 2017 · 4:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604665
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Units (Limited Partner Interests)F1 | Mar 9, 2017 | P | 2,500 | $25.4161 | A | 5,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1In accordance with the Securities and Exchange Commission's No Action Letter dated June 25, 2008, we have aggregated the purchase that occurred on March 9, 2017 for ease of reporting. The price reported in Column 4 is a weighted average price. These common units were purchased in multiple transactions ranging from $25.25 to $25.7, inclusive. The reporting person undertakes to provide to Westlake Chemical Partners LP, any security holder of Westlake Chemical Partners LP or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of common units purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
Remarks
Mr. Lumpkins is a Director of Westlake Chemical Partners GP LLC, the general partner of Westlake Chemical Partners LP.